AstraZeneca beats third-quarter sales estimate, backs 2020 outlook
By Syndicated ContentNov 5, 2020 | 2:17 AM
(Reuters) – AstraZeneca , the British drugmaker working on one of the world’s leading COVID-19 vaccine candidates, on Thursday beat third-quarter sales estimates on strong demand for its diverse portfolio of drugs during COVID-19 pandemic lockdowns and maintained its 2020 forecasts.
(Reporting by Pushkala Aripaka, Ludwig Burger in Frankfurt; Editing by Bernard Orr)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at (616) 392-3121.